Since cTRA2B antibodies identified a substantial additional proportion of RA patients not represented by either RF or ACPA, multivariable linear modeling was performed for different antibody combinations which were compared by likelihood ratio test. This evidence concerns the gene PRTN3 and rheumatoid arthritis.